Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

6.44
Delayed Data
As of 4:00pm ET
 +0.16 / +2.55%
Today’s Change
4.45
Today|||52-Week Range
13.08
-22.50%
Year-to-Date
Intrexon Corporation Surged 12% in November -- Here's Why
9:24am / MotleyFool.com - Paid Partner Content
3 Biotech Investing Tips That Could Earn You Thousands
Nov 28 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close6.28
Today’s open6.26
Day’s range6.06 - 6.50
Volume1,384,874
Average volume (3 months)1,875,039
Market cap$827.3M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-209.68%
Earnings growth (this year)-38.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.51%
P/E ratioNM
Price/Sales240.58
Price/Book9.47

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...0.000.00%
FWPForward Pharma A/S-0.44-2.45%
MGNXMacroGenics Inc+1.96+8.06%
INSYINSYS Therapeutics I...-0.11-0.99%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.3M
Annual profit (last year)-$120.1M
Net profit margin-2,772.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs